Medivation (MDVN) Said to Work with Bankers to Defend Against Takeover (SNY)

Go back to Medivation (MDVN) Said to Work with Bankers to Defend Against Takeover (SNY)

Medivation (MDVN) Worth $51-$75 in Takeover - Jefferies

March 31, 2016 11:40 AM EDT

Looking through the rumors, Jefferies analyst, Biren Amin, values shares of Medivation (NASDAQ: MDVN) in baseline and synergistic scenarios. However, he made no change to his Hold rating or $39 PT.

The baseline scenario values MDVN at $39/share thru a DCF, and included $200M of annual synergies from OpEx. The analyst assumed the acquirers tax rate and calculated a potential... More

Medivation (MDVN) Crosses Above 200 DMA Amid Takeover Speculation

March 31, 2016 10:12 AM EDT

Medivation (NASDAQ: MDVN), up early on takeover speculation, just crossed above its 200 Day Moving Average.

Shares are up 17.4% early to $43.89

... More

Medivation (MDVN) Could Be Worth Up to $75/Share in a Takeover - Credit Suisse

March 31, 2016 6:24 AM EDT

Credit Suisse analyst Kennen MacKay bumped his price target on Medivation (NASDAQ: MDVN) to $49.00 (from $48.00) following reports the company hired bankers to fend off a takeover. The firm maintained an Outperform rating.

The analyst notes Medivation has become vulnerable to a takeover given the... More

Medivation (MDVN) Has Indeed Hired Bakers - CNBC's Tirrell

March 30, 2016 5:32 PM EDT

Adding more credence to earlier reports, CNBC's Meg Tirrell reported that she can confirm that Medivation (NASDAQ: MDVN) has hired advisors, but does not plan to sell itself. The move is to protect against unwanted takeovers. Reuters reported JPMorgan is Medivation's... More

Medivation (MDVN) Working with JPMorgan on Takeover Approaches - Reuters

March 30, 2016 5:11 PM EDT

Medivation (NASDAQ: MDVN) Working with JPMorgan on Takeover Approaches - Reuters

... More

Sanofi (SNY) on watch; Medivation (MDVN) said to defend against potential takeover

March 30, 2016 4:23 PM EDT

Sanofi (NYSE: SNY) is on watch as Medivation (Nasdaq: MDVN) moves to defend a potential takeover.

StreetInsider.com previously reported that Sanofi might be eying Medivation. For more color, click here.

... More

Goldman Sachs Starts Medivation (MDVN) at Neutral

March 30, 2016 7:01 AM EDT

Goldman Sachs initiated coverage on Medivation (NASDAQ: MDVN) with a Neutral rating.

For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.

Shares of Medivation closed at $38.75 yesterday.

... More